APA (7th ed.) Citation

N, P., SL, N., C, R., M, W., DS, H., & JS, M. (2021). Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatric blood & cancer, 68(11), e29203. https://doi.org/10.1002/pbc.29203

Chicago Style (17th ed.) Citation

N, Pinto, Navarro SL, Rimorin C, Wurscher M, Hawkins DS, and McCune JS. "Pharmacogenomic Associations of Cyclophosphamide Pharmacokinetic Candidate Genes with Event-free Survival in Intermediate-risk Rhabdomyosarcoma: A Report from the Children's Oncology Group." Pediatric Blood & Cancer 68, no. 11 (2021): e29203. https://doi.org/10.1002/pbc.29203.

MLA (9th ed.) Citation

N, Pinto, et al. "Pharmacogenomic Associations of Cyclophosphamide Pharmacokinetic Candidate Genes with Event-free Survival in Intermediate-risk Rhabdomyosarcoma: A Report from the Children's Oncology Group." Pediatric Blood & Cancer, vol. 68, no. 11, 2021, p. e29203, https://doi.org/10.1002/pbc.29203.